Clinical Trials Sponsored by Ultra Laboratorios SA. de CV.

Total 14 results

Coordinación de Investigación en Salud, Mexico
Ultra Laboratorios SA. de CV.

Recruiting

Hidroxicloroquina With Azitromicina Versus Hidroxicloroquina and Placebo Int Patients With Mild COVID-19 (Omehecatl)

Covid19

Mexico
Distribuidora Biolife SA de CV

Enrolling by invitation

Efficacy of Nano-PSO in Parkinson's Disease.

Parkinson Disease

Mexico
Cindetec
Nucitec SA de CV

Completed

Partial Meal Replacement and Inulin in Obese Women

Obesity

Mexico
Omnilife Manufactura, SA de CV
University of Guadalajara

Completed

Effects of a Supplement on Acute Respiratory Infections

Respiratory Tract Infection

Mexico
Instituto Nacional de Cardiologia Ignacio Chavez
GSE Biomedical; Medstent SA de CV.

Withdrawn

First-in-Man Study: Safety and Efficacy of INC-1 Bare Metal Stent in the Novo Coronary Lesions.

Coronary Artery Disease | Stents | Treatment Outcome | Coronary Angiography | Angioplasty, Balloon, Coronary | Angioplasty | Humans

Mexico
Universidad de Guanajuato
Concejo de Ciencia y Tecnología del Estado de Guanajuato; Pisa SA de CV

Completed

Povidone-iodine Against Sodium Hypochlorite as Skin Antiseptics

Healthy Volunteers

Mexico
Laboratorios Manuell SA
Universidad Nacional Autonoma de Mexico

Unknown

Co-administration of Thiamine Pyrophosphate and Metformin in Type 2 Diabetes

Diabetes Mellitus, Type 2

Mexico
Laboratório Catarinense SA
Financiadora de Estudos e Projetos; Universidade Federal do Ceara

Terminated

Study to Evaluate the Efficacy of LABCAT TCJUSS in Patients With Depressive Episode (LABCATTCJUSS)

Depression

Brazil
GeNeuro SA
Worldwide Clinical Trials; Institut de Recherches Internationales Servier; Les...

Terminated

Assessing the HERV-W Env ANtagonist GNbAC1 for Evaluation in an Open Label Long-term Safety Study in Patients With Multiple Sclerosis (ANGEL-MS)

Multiple Sclerosis, Relapsing-Remitting

Estonia, Bulgaria, Croatia, Czechia, Germany, Hungary, Italy, Poland, Russian Federation, Serbia, Spain, Ukraine
GeNeuro SA
Worldwide Clinical Trials; Institut de Recherches Internationales Servier; Les...

Completed

Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS (CHANGE-MS)

Multiple Sclerosis, Relapsing-Remitting

Poland, Ukraine, Germany, Spain, Bulgaria, Serbia, Russian Federation, Hungary, Italy, Croatia, Czechia, Estonia
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
Germans Trias i Pujol Hospital; Institut Catala de Salut; Department of Health... and other collaborators

Completed

Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention (HCQ4COV19)

COVID-19

Spain
Collège National des Généralistes Enseignants
Assistance Publique - Hôpitaux de Paris; Institut National de la Santé Et de... and other collaborators

Completed

Study to Improve Quality of Care and Patient Health in the Field of Cardiovascular Risk Factors in General Practice (ESCAPE)

High Risk Hypertensive Patients

France
Monte Verde SA
FLENI Instituto de Rehabilitación y Educación Terapéutica, BA, Argentina.; Bioanalytical... and other collaborators

Completed

Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System

Brain Neoplasms, Malignant, Primary

Argentina
Institut National de la Santé Et de la Recherche...
Assistance Publique - Hôpitaux de Paris; Cardiff University; Karolinska Institutet and other collaborators

Withdrawn

TINN2: Treat Infection in NeoNates 2 (TINN2)

Bronchopulmonary Dysplasia

Belgium, France, Germany, Hungary, Italy, Luxembourg, Netherlands, Sweden, United Kingdom

Clinical Trials Sponsored by Ultra Laboratorios SA. de CV.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations